Abstract

ANZ Journal of SurgeryEarly View PERSPECTIVE Watch and wait in rectal cancer treatment- is it time to talk about regrowth? Amy Jayne Thomas MBChB, FRCS(Eng), Amy Jayne Thomas MBChB, FRCS(Eng) orcid.org/0000-0003-2612-0548 Division of Cancer Surgery, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia Contribution: Conceptualization, Data curation, Writing - original draft, Writing - review & editingSearch for more papers by this authorAmrish K. S. Rajkomar MBBS, FRACS, Amrish K. S. Rajkomar MBBS, FRACS orcid.org/0000-0001-8806-6028 General Surgery and Gastrointestinal Clinical Institute, EpworthHealthcare, Melbourne, Victoria, Australia Contribution: Writing - review & editingSearch for more papers by this authorAlexander Heriot FRACS, Alexander Heriot FRACS orcid.org/0000-0001-9846-8776 Division of Cancer Surgery, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia Contribution: Supervision, Writing - review & editingSearch for more papers by this authorSatish Warrier MBBS, FRACS, Satish Warrier MBBS, FRACS Division of Cancer Surgery, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia General Surgery and Gastrointestinal Clinical Institute, EpworthHealthcare, Melbourne, Victoria, Australia Contribution: Conceptualization, Supervision, Writing - review & editingSearch for more papers by this author Amy Jayne Thomas MBChB, FRCS(Eng), Amy Jayne Thomas MBChB, FRCS(Eng) orcid.org/0000-0003-2612-0548 Division of Cancer Surgery, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia Contribution: Conceptualization, Data curation, Writing - original draft, Writing - review & editingSearch for more papers by this authorAmrish K. S. Rajkomar MBBS, FRACS, Amrish K. S. Rajkomar MBBS, FRACS orcid.org/0000-0001-8806-6028 General Surgery and Gastrointestinal Clinical Institute, EpworthHealthcare, Melbourne, Victoria, Australia Contribution: Writing - review & editingSearch for more papers by this authorAlexander Heriot FRACS, Alexander Heriot FRACS orcid.org/0000-0001-9846-8776 Division of Cancer Surgery, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia Contribution: Supervision, Writing - review & editingSearch for more papers by this authorSatish Warrier MBBS, FRACS, Satish Warrier MBBS, FRACS Division of Cancer Surgery, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia General Surgery and Gastrointestinal Clinical Institute, EpworthHealthcare, Melbourne, Victoria, Australia Contribution: Conceptualization, Supervision, Writing - review & editingSearch for more papers by this author First published: 10 August 2024 https://doi.org/10.1111/ans.19192Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Kang SB, Cho JR, Jeong SY et al. Group (SECOG) SCR quality of life after sphincter preservation surgery or abdominoperineal resection for low rectal cancer (ASPIRE): a long-term prospective, multicentre, cohort study. Lancet Reg. Health West Pac. 2020; 6: 100087. PubMedGoogle Scholar 2Pappou EP, Temple LK, Patil S et al. Quality of life and function after rectal cancer surgery with and without sphincter preservation. Front. Oncol. 2022; 12: 944843. 10.3389/fonc.2022.944843 PubMedWeb of Science®Google Scholar 3Habr-Gama A, Perez RO, Nadalin W et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann. Surg. 2004; 240: 711–718. 10.1097/01.sla.0000141194.27992.32 PubMedWeb of Science®Google Scholar 4Maas M, Beets-Tan RGH, Lambregts DMJ et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J. Clin. Oncol. 2011; 29: 4633–4640. 10.1200/JCO.2011.37.7176 PubMedWeb of Science®Google Scholar 5Renehan AG, Malcomson L, Emsley R et al. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. Lancet Oncol. 2016; 17: 174–183. 10.1016/S1470-2045(15)00467-2 PubMedWeb of Science®Google Scholar 6Dossa F, Chesney TR, Acuna SA, Baxter NN. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 2017; 2: 501–513. 10.1016/S2468-1253(17)30074-2 PubMedWeb of Science®Google Scholar 7Verheij FS, Omer DMR, Williams H et al. Sustained organ preservation in patients with rectal cancer treated with total neoadjuvant therapy: long-term results of the OPRA trial. JCO 2023; 41: 3520. 10.1200/JCO.2023.41.16_suppl.3520 Google Scholar 8Habr-Gama A, Gama-Rodrigues J, São Julião GP et al. Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control. Int. J. Radiat. Oncol. Biol. Phys. 2014; 88: 822–828. 10.1016/j.ijrobp.2013.12.012 PubMedWeb of Science®Google Scholar 9Martens MH, Maas M, Heijnen LA et al. Long-term outcome of an organ preservation program after neoadjuvant treatment for rectal cancer. J. Natl. Cancer Inst. 2016; 108: djw171. 10.1093/jnci/djw171 PubMedGoogle Scholar 10van der Valk MJM, Hilling DE, Bastiaannet E et al. IWWD consortium. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet 2018; 391: 2537–2545. 10.1016/S0140-6736(18)31078-X PubMedWeb of Science®Google Scholar 11Kong JC, Guerra GR, Warrier SK, Ramsay RG, Heriot AG. Outcome and salvage surgery following "watch and wait" for rectal cancer after neoadjuvant therapy: a systematic review. Dis. Colon Rectum 2017; 60: 335–345. 10.1097/DCR.0000000000000754 PubMedWeb of Science®Google Scholar 12São Julião GP, Fernández LM, Vailati BB et al. Local regrowth and the risk of distant metastases among patients undergoing watch-and-wait for rectal cancer: what is the best control group? Multicenter retrospective study. Dis. Colon Rectum. 2024; 67: 73–81. 10.1097/DCR.0000000000002930 PubMedWeb of Science®Google Scholar 13Smith JJ, Strombom P, Chow OS et al. Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy. JAMA Oncol. 2019; 5: e185896. 10.1001/jamaoncol.2018.5896 PubMedWeb of Science®Google Scholar 14Fernandez LM, São Julião GP, Vailati BB et al. Organ preserving rectal cancer: what is at risk when offering watch and wait for a clinical complete response? Data from 2 international registries in rectal cancer. JCO. 2024; 42: 7. 10.1200/JCO.2024.42.3_suppl.7 Google Scholar 15Ferri V, Vicente E, Quijano Y et al. Light and shadow of watch-and-wait strategy in rectal cancer: oncological result, clinical outcomes, and cost-effectiveness analysis. Int. J. Colorectal Dis. 2023; 38: 277. 10.1007/s00384-023-04573-9 PubMedGoogle Scholar 16Fernandez LM, São Julião GP, Figueiredo NL et al. Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study. Lancet Oncol. 2021; 22: 43–50. 10.1016/S1470-2045(20)30557-X PubMedWeb of Science®Google Scholar 17Pennings AJ, Kimman ML, Gielen AHC, Beets GL, Melenhorst J, Breukink SO. Burden of disease experienced by patients following a watch-and-wait policy for locally advanced rectal cancer: a qualitative study. Colorectal Dis. 2021; 23: 2870–2878. 10.1111/codi.15838 PubMedWeb of Science®Google Scholar 18Tejedor P, Arredondo J, Pellino G, Pata F, Pastor C. Patient reported outcomes following cancer of the rectum (PROCaRe): protocol of prospective muticenter international study. Tech. Coloprotol. 2023; 27: 1345–1350. 10.1007/s10151-023-02865-4 PubMedGoogle Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation